News & Perspective

Aug 14, 2017

Aug 14, 2017
neurons

Brazilian study sheds new light on Zika neuro complications in adults

The patients, hospitalized at a speciality center, had a variety of complications and some unusual features.

May 11, 2005

May 11, 2005

West Nile vaccine looks good in early human trial

(CIDRAP News) – An initial human trial of a West Nile virus (WNV) vaccine has yielded promising results, officials said today.

In the double-blind, randomized trial, all but one of the people who received the vaccine developed antibodies to it, according to an Associated Press (AP) report quoting Dr. Thomas Monath, chief scientist at Acambis, the company that created the vaccine.

Apr 25, 2005

Apr 25, 2005

NIAID reports potential West Nile treatment

(CIDRAP News) – Researchers have developed an antibody that can cure mice of West Nile virus (WNV) infection, a disease for which no specific treatment now exists, the National Institute of Allergy and Infectious Diseases announced yesterday.

Apr 20, 2005

Nov 02, 2004

Nov 02, 2004

NIH funds research on how pathogens trigger immune response

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has awarded contracts worth more than $73 million to study the mechanisms by which certain infectious agents, including potential bioterror agents, trigger immune reactions, the National Institutes of Health (NIH) announced yesterday.

Jul 16, 2004

Jul 16, 2004

NIAID expands trial of West Nile treatment

Rev

Nov 07, 2003

Nov 07, 2003

Acambis launches clinical trial of West Nile vaccine

(CIDRAP News) – The British biotechnology company Acambis announced yesterday that it has launched the first clinical trial of its vaccine for West Nile virus, called ChimeriVax-West Nile.

The phase 1 trial will involve 60 adult volunteers in Lenexa, Kan., the company said in a news release. The volunteers will receive one of three doses of the West Nile vaccine or a licensed yellow fever vaccine that is being used as a control.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»